Analysed SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) News Sources
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
09-08-2026
yahoo.com
Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results
10-08-2026
yahoo.com
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
10-08-2026
yahoo.com
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
10-08-2026
yahoo.com
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial
11-08-2026
marketbeat.com
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
12-08-2026
yahoo.com
Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs
14-08-2026
yahoo.com
What is the current price of SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS)?
The current price of SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) is $3.85.
SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) since the previous trading day is $-0.15.
SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) since the previous trading day is -3.75%.
What is the most recent average sentiment score for SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS)?
The most recent average sentiment score for SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS)?
The most recent sentiment for SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS) is .
SEC-8K** Filing Available For SILENCE THERAPEUTICS PLC (SLNCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.